MR [Mindray Medical International] UPLOAD: (Original Filing)
[]
DQ [DAQO NEW ENERGY] 6-K: (Original Filing)
[Daqo New Energy Announces Second Quarter 2012 Results CHONGQING, ChinaAugust 17, 2012Daqo New Energy Corp. (NYSE: DQ) (Daqo New Energy or the Company), a leading polysilicon manufacturer based in China, today announced its unaudited financial results for the second quarter of 2012. Second Quarter 2012 Financial and Operating Highlights Polysilicon shipments were approximately 1028 metric tons, or MT. Photovoltaic]
DQ [DAQO NEW ENERGY] 6-K: Daqo New Energy Announces Second Quarter 2012 Results
[Daqo New Energy Announces Second Quarter 2012 Results CHONGQING, ChinaAugust 17, 2012Daqo New Energy Corp. (NYSE: DQ) (Daqo New Energy or the Company), a leading polysilicon manufacturer based in China, today announced its unaudited financial results for the second quarter of 2012. Second Quarter 2012 Financial and Operating Highlights Polysilicon shipments were approximately 1028 metric tons, or MT. Photovoltaic]
BSPM [Biostar Pharmaceuticals,] S-8: (Original Filing)
[FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang President and Chief Executive Officer No. 588 Shiji Xi Avenue] [Biostar Pharmaceuticals, Inc. 2011 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2011 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Cozen O’Connor Letterhead] August 16, 2012 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 Re: Registration Statement on Form S-8 Very truly yours, EX-5 3 ex5-1.htm] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 of Biostar Pharmaceuticals, Inc. of our report dated March 27, 2012 relating to the consolidation financial statements, which appears in the Annual Report on Form 10-K of Biostar Pharmaceuticals,]
BSPM [Biostar Pharmaceuticals,] S-8: FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT
[FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang President and Chief Executive Officer No. 588 Shiji Xi Avenue] [Biostar Pharmaceuticals, Inc. 2011 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2011 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Cozen O’Connor Letterhead] August 16, 2012 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 Re: Registration Statement on Form S-8 Very truly yours, EX-5 3 ex5-1.htm] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 of Biostar Pharmaceuticals, Inc. of our report dated March 27, 2012 relating to the consolidation financial statements, which appears in the Annual Report on Form 10-K of Biostar Pharmaceuticals,]
XUE [Xueda Education] 6-K: (Original Filing)
[Xueda Education Group Announces Second Quarter 2012 Financial Results Net Revenue Increased by 35.2% Year-Over-Year Total Cash Collections Increased by 52.0% Year-Over-Year Total Number of Learning Centers Increased by 127 Year-Over-Year to 383 Average Hourly Course Fee Increased by 9.5% Year-Over-Year Company Raised Full-year Revenue Guidance to $283-293 Million BEIJING, August 15, 2012 Xueda Education Group (NYSE: XUE) (Xueda] [TABLE OF CONTENTS 2 XUEDA EDUCATION GROUP]
FENG [Phoenix New Media] 6-K: (Original Filing)
[Results of Annual Shareholders Meeting Phoenix New Media Limited (Phoenix New Media, ifeng or the Company) held its annual general meeting of shareholders in Hong Kong on August 16, 2012 (Hong Kong time). 2 PHOENIX NEW MEDIA LIMITED Qianli LIU Chief Financial Officer]
